PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Miniature ‘plug-and-play’ platform could accelerate development of new PET tracers
Researchers are developing a system that combines a universal radioactive building block with different biological molecules to create new radiotracers.
FDA clears AI platform for PET imaging enhancement and quantification
The software supports amyloid, tau and FDG PET and provides automated Centiloid measurements for amyloid imaging and CenTauR measurements for tau imaging.
Physician groups launch national alliance to protect PET imaging access
The launch comes ahead of meetings with members of Congress this fall in Washington, D.C., where group leaders plan to advocate for the availability of cardiac PET, particularly among underserved populations.
Siemens Healthineers invests nearly $44M to boost PET/CT production
The finalized project was designed to increase production capacity and support growing demand for PET/CT technology, including new product lines planned for the United States and international markets.
Bayer's investigational PET tracer shows high accuracy for cardiac amyloidosis
The imaging agent could offer a new approach for diagnosing stiff heart syndrome, according to data presented during the European Society of Cardiology Congress.

Software glitch prompts FDA recall of popular PET systems

The recall was issued due to the potential for the systems to produce artifacts during PET exams.

PET-CT imaging of 124-I evuzamitide and SPECT-CT imaging of 99mTc-p5+14 showed radiotracer uptake in both AL and ATTR amyloid throughout the myocardium. Emily B. Martin, Anne Kassira, Alan Stuckey, et al. A tale of two tracers - Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). https://www.journalofnuclearcardiology.org/article/S1071-3581(25)00325-3/abstract.

Bayer expands into molecular imaging with cardiac amyloidosis tracer acquisitions

Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis.

Sarah-Jane James, CT, MRI, molecular imaging senior market analyst for Signify Research, explains key trends in imaging systems she saw at the Radiological Society of North America (RSNA) 2025 meeting.

Key trends in medical imaging systems at RSNA 2025

Sarah-Jane James, imaging market analyst for Signify Research, discusses key trends in the specialty that she saw at the Radiological Society of North America's annual meeting.

Positron NeuSight PET-CT 64 slice scanner

Positron raises $2M to expand PET-CT commercialization

The New York-based imaging company is now focused on expanding sales for the cost-effective PET-CT system it developed with Neusoft Medical Systems.

Leading nuclear medicine organizations collaborate to streamline PET accreditation

The groups have jointly endorsed a unified framework “to standardize and harmonize quantitative PET imaging worldwide.”

Copper-based radiotracer excels at PSMA imaging

Copper-based PSMA radiotracer shines in clinical trial

The tracer's extended half-life of over three hours could make it a promising candidate for future prostate cancer diagnostics.

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients

The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.

UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics

“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman.

PET/CT

Miniature ‘plug-and-play’ platform could accelerate development of new PET tracers

FDA clears AI platform for PET imaging enhancement and quantification

Physician groups launch national alliance to protect PET imaging access

Siemens Healthineers invests nearly $44M to boost PET/CT production

Bayer's investigational PET tracer shows high accuracy for cardiac amyloidosis